Professional
Added to YB: 2025-05-23
Pitch date: 2025-05-09
GSK [neutral]
GSK plc
+40.56%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
Market Cap
GBP 72.9B
Pitch Price
GBP 12.98
Price Target
N/A
Dividend
3.36%
EV/EBITDA
8.93
P/E
13.65
EV/Sales
2.70
Sector
Pharmaceuticals
Category
value
Show full summary:
Pzena International Value New Position: GSK plc
GSK (new position): Market discounting durability of vaccine & HIV treatment businesses, while specialty medicine pipeline has promising treatments nearing commercialization.
Read full article (1 min)